Activin pathway inhibition and rapid progression of malignancy in pulmonary arterial hypertension: A case series and hypothesis.
- DOI
- 10.1016/j.rmed.2026.109151
- Published
- 2026 Sep 11
- Container
- Respiratory medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.rmed.2026.109151,
title = {Activin pathway inhibition and rapid progression of malignancy in pulmonary arterial hypertension: A case series and hypothesis.},
author = {Tonelli AR and Aulak KS and Berro J and Highland KB},
year = {2026},
journal = {Respiratory medicine},
doi = {10.1016/j.rmed.2026.109151},
url = {https://doi.org/10.1016/j.rmed.2026.109151}
}RIS
TY - JOUR TI - Activin pathway inhibition and rapid progression of malignancy in pulmonary arterial hypertension: A case series and hypothesis. AU - Tonelli AR AU - Aulak KS AU - Berro J AU - Highland KB PY - 2026 JO - Respiratory medicine DO - 10.1016/j.rmed.2026.109151 UR - https://doi.org/10.1016/j.rmed.2026.109151 ER -
APA
AR, T., KS, A., J, B., & KB, H. (2026). Activin pathway inhibition and rapid progression of malignancy in pulmonary arterial hypertension: A case series and hypothesis.. Respiratory medicine. https://doi.org/10.1016/j.rmed.2026.109151
Source records
- pubmed · retrieved 2026-09-26T22:39:53.793Z